Streetbeat News

Stock Prices

BPTH

CAMP

CNSP

GME

LSCC

MBOT

SAIC

U.S. stocks traded mostly lower with the Dow Jones falling over 300 points. GameStop shares spiked 35% after a Reddit post by Roaring Kitty. Bio-Path Holdings and Microbot Medical saw significant gains due to positive news, while CalAmp Corp shares plummeted 60% following a Chapter 11 bankruptcy filing. Lattice Semiconductor and CNS Pharmaceuticals also experienced notable declines.

Portfolio Pulse from Avi Kapoor

June 03, 2024 | 6:35 pm

PBYI

Puma Biotechnology presented a Phase I/Ib study on Alisertib for treating Osimertinib-resistant EGFR-mutated lung cancer at ASCO 2024.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:33 pm

JNJ

Johnson & Johnson announced new Phase 2 data from the PALOMA-2 study showing that subcutaneous amivantamab combined with lazertinib provides a clinically meaningful antitumor response and improved safety profile in patients with EGFR-mutated non-small cell lung cancer. The results were presented at the 2024 ASCO Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:33 pm

MRUS

Merus N.V. (NASDAQ:MRUS) presented a poster at the 2024 ASCO Annual Meeting showcasing the single-agent efficiency of MCLA-129 in METex14 NSCLC.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:31 pm

UMBF

UMB Financial's short interest has risen by 204.11% since its last report, with 1.71 million shares sold short, representing 4.44% of its float. This increase in short interest could indicate bearish sentiment among investors. However, UMB Financial's short interest is still below the peer group average of 5.04%.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 6:30 pm

NVO

Novo Nordisk (NYSE:NVO) has significantly outperformed the market over the past 10 years, delivering an average annual return of 19.79%. A $100 investment in NVO 10 years ago would now be worth $626.97. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 6:30 pm

PSTG

Pure Storage (NYSE:PSTG) has significantly outperformed the market over the past 5 years, delivering an average annual return of 30.72%. A $100 investment in PSTG 5 years ago would now be worth $381.19. The company's current market capitalization is $19.23 billion.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 6:30 pm

OCX

Oncocyte's VitaGraft Kidney Diagnostic Test has shown promising Phase 2 results in transplant monitoring, as published in the New England Journal of Medicine.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:15 pm

ALBT

Avalon GloboCare shares have resumed trading after a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:14 pm

AFMD

Affimed N.V. (NASDAQ: AFMD) shares surged on Monday following the release of promising clinical data from its AFM24-102 study in non-small cell lung cancer (NSCLC). The data showed significant clinical efficacy and a manageable safety profile for the combination of AFM24 and atezolizumab, leading to an 81.4% increase in AFMD's stock price.

Portfolio Pulse from Vandana Singh

June 03, 2024 | 6:13 pm